Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Color Diagnostics, |
RCV001182796 | SCV001348377 | likely benign | Cardiomyopathy | 2024-08-29 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV001340500 | SCV001534314 | uncertain significance | Arrhythmogenic right ventricular dysplasia 10 | 2020-06-21 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine with isoleucine at codon 238 of the DSG2 protein (p.Thr238Ile). The threonine residue is moderately conserved and there is a moderate physicochemical difference between threonine and isoleucine. This variant is present in population databases (rs767523704, ExAC 0.006%). This variant has not been reported in the literature in individuals with DSG2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The isoleucine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Ambry Genetics | RCV002365863 | SCV002665488 | likely benign | Cardiovascular phenotype | 2025-02-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| All of Us Research Program, |
RCV004008325 | SCV004819468 | likely benign | Arrhythmogenic right ventricular cardiomyopathy | 2023-08-15 | criteria provided, single submitter | clinical testing |